Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
UCL School of Pharmacy, University College London, London, UK.
J Antimicrob Chemother. 2021 Aug 12;76(9):2464-2471. doi: 10.1093/jac/dkab187.
Understanding antimicrobial consumption is essential to mitigate the development of antimicrobial resistance, yet robust data in children are sparse and methodologically limited. Electronic prescribing systems provide an important opportunity to analyse and report antimicrobial consumption in detail.
We investigated the value of electronic prescribing data from a tertiary children's hospital to report temporal trends in antimicrobial consumption in hospitalized children and compare commonly used metrics of antimicrobial consumption.
Daily measures of antimicrobial consumption [days of therapy (DOT) and DDDs] were derived from the electronic prescribing system between 2010 and 2018. Autoregressive moving-average models were used to infer trends and the estimates were compared with simulated point prevalence surveys (PPSs).
More than 1.3 million antimicrobial administrations were analysed. There was significant daily and seasonal variation in overall consumption, which reduced annually by 1.77% (95% CI 0.50% to 3.02%). Relative consumption of meropenem decreased by 6.6% annually (95% CI -3.5% to 15.8%) following the expansion of the hospital antimicrobial stewardship programme. DOT and DDDs exhibited similar trends for most antimicrobials, though inconsistencies were observed where changes to dosage guidelines altered consumption calculation by DDDs, but not DOT. PPS simulations resulted in estimates of change over time, which converged on the model estimates, but with much less precision.
Electronic prescribing systems offer significant opportunities to better understand and report antimicrobial consumption in children. This approach to modelling administration data overcomes the limitations of using interval data and dispensary data. It provides substantially more detailed inferences on prescribing patterns and the potential impact of stewardship interventions.
了解抗菌药物的使用对于减轻抗菌药物耐药性的发展至关重要,但儿童方面的可靠数据很少,且方法学上存在局限性。电子处方系统为详细分析和报告抗菌药物使用情况提供了重要机会。
我们调查了一家三级儿童医院的电子处方数据的价值,以报告住院儿童中抗菌药物使用的时间趋势,并比较常用的抗菌药物使用衡量指标。
从电子处方系统中获取 2010 年至 2018 年期间的每日抗菌药物使用量(治疗日数[DOT]和限定日剂量[DDD])数据。使用自回归移动平均模型推断趋势,并将估计值与模拟的时点患病率调查(PPS)进行比较。
分析了超过 130 万次抗菌药物给药。总体使用量存在明显的日和季节性变化,每年减少 1.77%(95%CI 0.50%至 3.02%)。在医院抗菌药物管理计划扩大后,美罗培南的相对使用量每年减少 6.6%(95%CI -3.5%至 15.8%)。对于大多数抗菌药物,DOT 和 DDDs 表现出相似的趋势,但在改变剂量指南改变 DDD 计算而不是 DOT 的情况下,观察到了不一致的情况。PPS 模拟导致了随时间变化的估计值,这些估计值与模型估计值趋同,但精度要低得多。
电子处方系统为更好地了解和报告儿童的抗菌药物使用提供了重要机会。这种管理数据建模的方法克服了使用区间数据和配药数据的局限性。它提供了关于处方模式和管理干预潜在影响的更详细推断。